Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFPODOXIME PROXETIL vs CEFTIBUTEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFPODOXIME PROXETIL vs CEFTIBUTEN: Safety Overview

Metric CEFPODOXIME PROXETIL CEFTIBUTEN
Total FAERS Reports 323 150
Deaths Reported 5 1
Death Rate 1.5% 0.7%
Hospitalizations 160 26
Average Patient Age 52.9 yrs 37.1 yrs
% Female Patients 70.0% 58.9%
FDA Approval Date Aug 20, 2003 Dec 20, 1995
Manufacturer Amici Pharmaceuticals, LLC. N/A
Route ORAL N/A
Marketing Status Discontinued Discontinued